Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Exploring 3 High Growth Tech Stocks in the US Market

In This Article:

In the last week, the United States market has remained flat, yet it has achieved an 8.1% increase over the past year with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and expansion within a stable and upward-trending market environment.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

20.31%

30.44%

★★★★★★

TG Therapeutics

26.18%

37.61%

★★★★★★

Alkami Technology

20.45%

85.16%

★★★★★★

Travere Therapeutics

28.43%

65.01%

★★★★★★

AVITA Medical

27.74%

55.36%

★★★★★★

Clene

61.16%

59.11%

★★★★★★

TKO Group Holdings

22.48%

25.17%

★★★★★★

Alnylam Pharmaceuticals

22.76%

58.08%

★★★★★★

Lumentum Holdings

21.55%

119.67%

★★★★★★

Ascendis Pharma

32.36%

59.79%

★★★★★★

Click here to see the full list of 240 stocks from our US High Growth Tech and AI Stocks screener.

We'll examine a selection from our screener results.

Mirum Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★☆

Overview: Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative treatments for rare and orphan diseases, with a market cap of $2.30 billion.

Operations: Mirum Pharmaceuticals focuses on developing and commercializing therapies for rare and orphan diseases, generating $336.89 million in revenue from its pharmaceuticals segment.

Mirum Pharmaceuticals, despite its current unprofitability, is navigating a promising trajectory with an expected revenue growth of 21.1% annually, outpacing the US market's 8.4%. This growth is bolstered by its recent FDA approval for Ctexli, a groundbreaking treatment for CTX, highlighting its commitment to addressing rare diseases with significant unmet medical needs. Moreover, the company's R&D focus remains robust as evidenced by substantial investments aimed at expanding its product pipeline and enhancing drug efficacy—crucial steps toward profitability and market relevance in the competitive biotech landscape.

NasdaqGM:MIRM Earnings and Revenue Growth as at Mar 2025
NasdaqGM:MIRM Earnings and Revenue Growth as at Mar 2025

Alkami Technology

Simply Wall St Growth Rating: ★★★★★★

Overview: Alkami Technology, Inc. offers cloud-based digital banking solutions in the United States and has a market capitalization of approximately $2.71 billion.

Operations: Alkami Technology generates revenue primarily from its Internet Software & Services segment, which accounts for $333.85 million. The company focuses on providing cloud-based digital banking solutions within the U.S. market.